100 Participants Needed

Bankart + Remplissage Procedure for Shoulder Dislocation

(REDUCE Trial)

MG
MK
DD
DD
Overseen ByDanielle Dagher, MSc
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine whether surgery or non-surgical options are more effective for individuals experiencing their first shoulder dislocation. The study compares a surgical method called Bankart repair (a type of shoulder surgery), with or without an additional step called Remplissage, to non-surgical treatments. It targets individuals who have dislocated their shoulder within the past three months. Participants must have experienced an anterior shoulder dislocation and confirmed it through tests or a doctor's examination. As an unphased trial, this study allows participants to contribute to valuable research that could enhance future treatment options.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the Bankart +/- Remplissage Procedure is safe for shoulder dislocation?

Research has shown that combining Bankart repair and Remplissage is generally well-tolerated for treating shoulder dislocations. Past studies reported a failure rate between 2% and 15%, indicating that only a small number of patients experienced issues. In another study, about 4% of patients had a positive apprehension test, indicating shoulder instability. Most patients reported excellent shoulder function after the procedure, achieving high scores on tests measuring shoulder health. Overall, the treatment appears to reduce the likelihood of the shoulder dislocating again, suggesting it is relatively safe and effective for many people.12345

Why are researchers excited about this trial?

Researchers are excited about the Bankart + Remplissage procedure for shoulder dislocation because it offers a dual approach that aims to improve stability and reduce the risk of future dislocations. Unlike traditional treatments that typically focus solely on repairing the torn labrum (like the standard Bankart repair), this procedure adds the remplissage technique, which fills a bony defect in the shoulder with tissue from the surrounding area. This dual-action method not only addresses the labral tear but also tackles bone loss, which is a common issue in recurring dislocations. By doing so, it holds the promise of a more comprehensive and lasting solution for individuals with shoulder instability.

What evidence suggests that this trial's treatments could be effective for shoulder dislocation?

Research has shown that combining the Bankart procedure with remplissage for shoulder dislocation is promising. In this trial, some participants will receive the Bankart repair with remplissage, while others will receive conservative treatment. Studies indicate that the failure rate of the combined Bankart and remplissage approach ranges from 2-15%, which is quite low. Younger patients, in particular, have experienced good long-term results. This procedure significantly reduces the risk of shoulder instability during movement. Overall, evidence suggests that this treatment effectively improves shoulder stability and function.13678

Who Is on the Research Team?

Moin Khan - MIRA

Moin Khan, MD

Principal Investigator

McMaster University

Are You a Good Fit for This Trial?

This trial is for men and women aged 14-50 who've had a first-time shoulder dislocation confirmed by X-rays or physical exam. It's not for those with previous shoulder surgery, bone defects in the glenoid, contraindications to anesthesia, pregnancy, nursing mothers, inability to have surgery, other serious injuries like full cuff tears, risk of incarceration or delayed treatment over 90 days post-dislocation.

Inclusion Criteria

I am between 14 and 40 years old.
My shoulder was dislocated for the first time in the last 3 months, confirmed by a doctor.
Provision of informed consent

Exclusion Criteria

Bony glenoid defect (bony Bankart) >10% as measured on preop imaging
I have had shoulder surgery before.
Patients that will likely have problems with maintaining follow-up or are incarcerated
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either arthroscopic surgical stabilization or non-operative management for first-time shoulder dislocation

3 months
Multiple visits for surgical or physical therapy sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

24 months
Visits at 6 weeks, 6 months, 12 months, and 24 months post-treatment

Extension/Long-term follow-up

Participants may continue to be monitored for long-term outcomes and recurrence of dislocation

Additional follow-up as needed

What Are the Treatments Tested in This Trial?

Interventions

  • Bankart +/- Remplissage Procedure
Trial Overview The study compares arthroscopic soft tissue stabilization (Bankart + Remplissage Procedure) against non-surgical treatments in patients after their first shoulder dislocation. The goal is to see which method better prevents future dislocations and improves function over two years.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Bankart repair + Remplissage (randomized cohort)Experimental Treatment1 Intervention
Group II: Bankart repair + Remplissage (non-randomized cohort)Experimental Treatment1 Intervention
Group III: Conservative treatment (randomized cohort)Active Control1 Intervention
Group IV: Conservative treatment (non-randomized cohort)Active Control1 Intervention

Bankart +/- Remplissage Procedure is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Bankart Repair for:
🇺🇸
Approved in United States as Bankart Repair for:
🇨🇦
Approved in Canada as Bankart Repair for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+

Published Research Related to This Trial

In a study of 53 patients with recurrent anterior shoulder dislocation, adding remplissage to Bankart repair significantly reduced residual apprehension compared to Bankart repair alone, with 32% of the remplissage group experiencing apprehension versus 71.4% in the control group.
Both groups showed improvement in clinical scores post-surgery, but the remplissage group had better outcomes in ROWE scores, indicating enhanced shoulder stability without causing external rotation deficits.
Remplissage in Addition to Arthroscopic Bankart Repair for Shoulder Instability With On-Track Hill-Sachs Lesions Reduces Residual Apprehension Without External Rotation Limitation.Yu, W., Kim, H., Seo, JH., et al.[2023]
The remplissage technique, combined with Bankart lesion repair, significantly improved shoulder function in patients with recurrent anterior dislocation, as shown by a notable increase in Rowe and UCLA scores after surgery.
The procedure had a low complication rate, with only two patients experiencing recurrence of instability, and no pain reported in the infraspinatus tendon post-operation, indicating its safety and efficacy in treating glenohumeral instability.
RESULTS FROM FILLING "REMPLISSAGE" ARTHROSCOPIC TECHNIQUE FOR RECURRENT ANTERIOR SHOULDER DISLOCATION.Gracitelli, ME., Helito, CP., Malavolta, EA., et al.[2022]
In a study of 65 patients with recurrent anterior shoulder instability, the combination of arthroscopic remplissage and classic Bankart repair resulted in a low recurrence rate of only 5.6% for dislocations over an average follow-up of 8.1 years.
Patients reported high satisfaction with the surgical outcome, with significant improvements in shoulder function scores and no significant restrictions in shoulder range of motion, indicating that this procedure is both safe and effective for treating engaging Hill-Sachs lesions.
Long-term outcome of arthroscopic remplissage in addition to the classic Bankart repair for the management of recurrent anterior shoulder instability with engaging Hill-Sachs lesions.Brilakis, E., Avramidis, G., Malahias, MA., et al.[2020]

Citations

Clinical Outcome of Arthroscopic Bankart Repair and ...The overall failure rate with combined arthroscopic Bankart and Remplissage was found to be 2-15%. The purpose of this study was to prospectively study clinical ...
a systematic review and meta-analysisNo difference in outcomes after arthroscopic Bankart repair with remplissage or arthroscopic latarjet procedure for anterior shoulder ...
Bankart repair and remplissage for surgical treatment of ...The results of this study demonstrate that arthroscopic Bankart repair combined with remplissage provides favorable long-term outcomes in young ...
Visualizing the Effect of Arthroscopic Bankart Repair and ...Arthroscopic Bankart repair combined with remplissage significantly reduced AHHT at 90° of abduction, whereas Bankart repair alone showed no ...
Arthroscopic Bankart Repair With Remplissage Results in ...Clinical and functional outcomes of the remplissage technique to repair anterior shoulder dislocation: average 7 years of follow-up.
Arthroscopic Bankart and Remplissage for Anteroinferior ...A failure rate of 4.17% (1 patient with a positive apprehension test) was seen. Conclusions. Arthroscopic Bankart repair with the remplissage procedure helps to ...
Remplissage with Bankart repair in “on track” lesions are ...These patients had excellent functional outcomes according to Rowe score (>90) and Oxford Shoulder Score (>40).
Arthroscopic Bankart with remplissage results in lower rates of ...Pooled results, with low statistical heterogeneity, demonstrated a significantly lower rate of recurrent dislocations following Bankart repair ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security